Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis

Clinical Laboratory

Volumn 57, Issue 11-12, 2011, Pages 947-952

  Zhu, Xuejing ^a   Liu, Fuyou ^a   Liu, Yinghong ^a   Liu, Hong ^a   Xu, Xiangqing ^a   Peng, Youming ^a   Sun, Lin ^a,b   Yuan, Shuguang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Biopsy; Pathological type; Renal amyloidosis

Indexed keywords

PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; KIDNEY AMYLOIDOSIS; LIGHT CHAIN; MALE; NEPHROTIC SYNDROME; PROTEIN BLOOD LEVEL; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL;

ADULT; AGED; AMYLOID; AMYLOIDOSIS; BIOPSY; CHINA; COLORING AGENTS; CONGO RED; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; INCIDENCE; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; SERUM AMYLOID A PROTEIN;

EID: 83455212206     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ozdemir D, Dagdelen S, Erbas T. Endocrine involvement in systemic amyloidosis. Endocr Pract 2010;16(6):1056-63.
2. Morishige M, Abe T, Kamida T, et al. Cerebral vasculitis associated with amyloid angiopathy: case report. Neurol Med Chir (Tokyo)2010;50(4):336-8.
3. Blank N, Lorenz HM. [Diagnostics and therapy of AA amyloidosis]. Pathologe 2009;30(3):219-25.
4. Rumpelt HJ, Steinke A, Thoenes W. Alport-type glomerulopathy: evidence for diminished capillary loop size. Clin Nephrol 1992; 37(2):57-64.
5. Ishitobi F, Sagiya A, Ueda Y, Oka K, Kanaya H, Iidaka K. Morphometry analysis of the glomerular capillary area - a compareson of minimal change nephrotic syndrome, focal glomerular sclerosis, and pre-eclampsia. J Pathol 1991;165(4):329-36.
6. Toth T, Takebayashi S. Glomerular hypertrophy as a prognostic marker in childhood IgA nephropathy. Nephron 1998;80(3):285-91. (Pubitemid 28502317)
7. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
8. Qu Z, Zheng X, Wang SX, et al. Clinical and pathological features of renal amyloidosis: an analysis of 32 patients in a single Chinese centre. Nephrology (Carlton)2010;15(1):102-7.
9. Looi LM, Cheah PL. Histomorphological patterns of renal amyloidosis: a correlation between histology and chemical type of amyloidosis. Hum Pathol 1997;28(7):847-9.
10. Shah VB, Phatak AM, Shah BS, Kandalkar BM, Haldankar AR, Ranganathan S. Renal amyloidosis - a clinicopathologic study. Indian J Pathol Microbiol 1996;39(3):179-85. (Pubitemid 126505299)
11. Palma CL, Grunholz D, Osorio G. [Clinical features of patients with the pathological diagnosis of amyloidosis]. Revista medica de Chile 2005;133(6):655-61.
12. Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR. Amyloidosis. Best practice & research 2005;18(4):709-27.
13. Sykora R, Radej J, Novak I, et al. [Persistent diarrhoea, hypotension, polyneuropathy]. Vnitrni lekarstvi 2008;54(11):1106-10.
14. Shafique S, Wetmore J, Almehmi A. Primary amyloidosis of the kidney. The West Virginia Medical Journal 2010;106(1):22-4.
15. Esteve V, Almirall J, Ponz E, et al. [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival]. Nefrologia 2006;26(2):212-7.
16. Novak L, Cook WJ, Herrera GA, Sanders PW. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant 2004;19(12):3050-3. (Pubitemid 40057627)
17. Danilewicz M, Wagrowska-Danilewicz M. Quantitative analysis of interstitial mast cells in AA and AL renal amyloidosis. Pathology, research and practice 2002;198(6):413-9. (Pubitemid 34823504)